Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05516472 · ClinicalTrials.gov registry record · Early Phase 1
Fecal Microbiota Transplantation in Kidney Stone Patients
A Early Phase 1 study of Kidney Stones, sponsored by Joshua Stern.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT05516472: Recruiting Early Phase 1 study of Kidney Stones, sponsored by Joshua Stern.
NCT05516472 is a Early Phase 1 study of Kidney Stones that is actively recruiting participants, run by Joshua Stern. The registered enrollment target is 36 participants, below the 292-participant average among 15 other Kidney Stones trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05516472, a Early Phase 1 study of Kidney Stones, is actively recruiting participants, sponsored by Joshua Stern.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to measure the impact of Microbial Transplant Therapy (MTT) on 24-hour urine parameters in recurrent hypercalciuric and hyperoxaluric kidney stone formers.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Microbial Transplant Therapy
Study Locations (1)
Utah
- Park City Hospital - Park City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2024-10-10 |
| Est. Completion | 2027-03 |
| Phase | Early Phase 1 |
What NCT05516472 shows while recruiting
NCT05516472 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 292-participant average among 15 other Kidney Stones trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Kidney Stones appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05516472 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT05516472 about?
NCT05516472 is a clinical study titled "Fecal Microbiota Transplantation in Kidney Stone Patients". The purpose of this study is to measure the impact of Microbial Transplant Therapy (MTT) on 24-hour urine parameters in recurrent hypercalciuric and hyperoxaluric kidney stone formers.
What is the current status of trial NCT05516472?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 36 participants. The study started on 2024-10-10. Estimated completion is 2027-03.
What conditions does trial NCT05516472 study?
This clinical trial studies the following conditions: Kidney Stones.
What interventions are being tested in trial NCT05516472?
The interventions under investigation include: Placebo (DRUG), Microbial Transplant Therapy (DRUG).
Who is sponsoring clinical trial NCT05516472?
This trial is sponsored by Joshua Stern, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05516472 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Stones
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05516472's enrollment target sits among peer trials
36 11th of 15 higher than 5 of 15 other Kidney Stones trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Stones trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SGLT2i in Kidney Stones
RECRUITING · Early Phase 1
-
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
-
Evaluation of Eye Gaze Sharing in the Operating Room
RECRUITING · NA
-
Thulium Fiber Laser (TFL) vs Thulio Pulsed Thulium:YAG (p-Tm:YAG)
RECRUITING · NA
-
CaOx Stone Prevention
RECRUITING · Phase 4
-
Eye Gaze Guidance Evaluation in Phantoms
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI